{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:12:19Z","timestamp":1772608339711,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.aprim.2022.102354","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T07:16:23Z","timestamp":1652339783000},"page":"102354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metformina en el tratamiento de enfermedades dermatol\u00f3gicas: una revisi\u00f3n narrativa"],"prefix":"10.1016","volume":"54","author":[{"given":"Juan","family":"Monte-Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Villagrasa-Boli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Crua\u00f1es-Monferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Arbu\u00e9s-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mart\u00ednez-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Fernando","family":"Garc\u00eda-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102354_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res."},{"key":"10.1016\/j.aprim.2022.102354_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0253-7613.174388","article-title":"Metformin - For the dermatologist","volume":"48","author":"Bubna","year":"2016","journal-title":"Indian J Pharmacol."},{"key":"10.1016\/j.aprim.2022.102354_bib0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.36849\/JDD.2020.4874","article-title":"Oral metformin for treating dermatological diseases: A systematic review","volume":"19","author":"Sung","year":"2020","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.aprim.2022.102354_bib0105","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.1111\/dth.12953","article-title":"Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study","author":"Robinson","year":"2019","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.aprim.2022.102354_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13543784.2018.1412430","article-title":"Investigational drugs in clinical trials for Hidradenitis Suppurativa","volume":"27","author":"Theut Riis","year":"2017","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1016\/j.aprim.2022.102354_bib0115","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.3390\/ijms21238960","article-title":"A molecular perspective on the potential benefits of metformin for the treatment of inflammatory skin disorders","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.aprim.2022.102354_bib0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CCID.S137527","article-title":"Current treatment options for acanthosis nigricans","volume":"11","author":"Patel","year":"2018","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"10.1016\/j.aprim.2022.102354_bib0125","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2174\/1381612822666160720151243","article-title":"Hirsutism in polycystic ovary syndrome: Pathophysiology and management","volume":"22","author":"Spritzer","year":"2016","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.aprim.2022.102354_bib0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00105-009-1847-5","article-title":"65-j\u00e4hriger Patient mit gelb-orange farbenen Papeln an beiden Unterarmen","volume":"60","author":"Streit","year":"2009","journal-title":"Hautarzt."},{"key":"10.1016\/j.aprim.2022.102354_bib0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2021.02.042","article-title":"Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland","volume":"85","author":"Adalsteinsson","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.aprim.2022.102354_bib0140","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jaad.2021.04.105","article-title":"Metformin use and keratinocyte carcinoma risk","volume":"85","author":"Misitzis","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.aprim.2022.102354_bib0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/2159-8290.CD-11-0280","article-title":"Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A","volume":"2","author":"Martin","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.aprim.2022.102354_bib0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cancers12030668","article-title":"Metformin as an adjuvant to photodynamic therapy in resistant basal cell carcinoma cells","volume":"12","author":"Mascaraque","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.aprim.2022.102354_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2021.02.002","article-title":"Possible treatment for UVB-induced skin injury: Anti-inflammatory and cytoprotective role of metformin in UVB-irradiated keratinocytes","volume":"102","author":"Xiao","year":"2021","journal-title":"J Dermatol Sci."},{"key":"10.1016\/j.aprim.2022.102354_bib0160","doi-asserted-by":"crossref","first-page":"101456","DOI":"10.1016\/j.arr.2021.101456","article-title":"How good is the evidence that cellular senescence causes skin ageing?","volume":"71","author":"Low","year":"2021","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.aprim.2022.102354_bib0165","doi-asserted-by":"crossref","first-page":"111588","DOI":"10.1016\/j.mad.2021.111588","article-title":"Promises and challenges of senolytics in skin regeneration, pathology and ageing","volume":"200","author":"Pils","year":"2021","journal-title":"Mech Ageing Dev."},{"key":"10.1016\/j.aprim.2022.102354_bib0170","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/acel.12635","article-title":"Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application","volume":"16","author":"Zhao","year":"2017","journal-title":"Aging Cell."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:02:27Z","timestamp":1759323747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0212656722000749"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102354","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformina en el tratamiento de enfermedades dermatol\u00f3gicas: una revisi\u00f3n narrativa","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102354"}}